Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective
Saved in:
| Published in: | Health Economics Review |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1869119643988262914 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Health Economics Review |
| description | |
| discipline_display | Economic Sciences General |
| discipline_facet | Economic Sciences General |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:96403 |
| institution | FRELIP |
| journal_source_facet | Health Economics Review |
| last_indexed | 2026-06-27T03:36:38.480Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective Economic Sciences General General Economic Sciences General |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Economic Sciences General General Economic Sciences General |
| subject_facet | Economic Sciences General General Economic Sciences General |
| title | Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective |
| title_alt | Reducción de recurrencias del cáncer de mama con tratamiento con inhibidores de CDK4/6 en cáncer de mama en etapa temprana HR positivo, HER2 negativo desde una perspectiva social Réduction des récidives du cancer du sein par traitement par inhibiteur de CDK4/6 du cancer du sein précoce HR-positif, HER2-négatif d'un point de vue sociétal Redução de recorrências de câncer de mama com tratamento com inibidor de CDK4/6 para câncer de mama em estágio inicial HR-positivo, HER2-negativo sob uma perspectiva social |
| title_auth | Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective |
| title_es_txt | Reducción de recurrencias del cáncer de mama con tratamiento con inhibidores de CDK4/6 en cáncer de mama en etapa temprana HR positivo, HER2 negativo desde una perspectiva social |
| title_fr_txt | Réduction des récidives du cancer du sein par traitement par inhibiteur de CDK4/6 du cancer du sein précoce HR-positif, HER2-négatif d'un point de vue sociétal |
| title_full | Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective |
| title_fullStr | Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective |
| title_full_unstemmed | Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective |
| title_pt_txt | Redução de recorrências de câncer de mama com tratamento com inibidor de CDK4/6 para câncer de mama em estágio inicial HR-positivo, HER2-negativo sob uma perspectiva social |
| title_short | Reducing breast cancer recurrences with CDK4/6 inhibitor treatment of HR-positive, HER2-negative early stage breast cancer from a societal perspective |
| title_sort | reducing breast cancer recurrences with cdk4/6 inhibitor treatment of hr-positive, her2-negative early stage breast cancer from a societal perspective |
| topic | Economic Sciences General General Economic Sciences General |
| url | https://link.springer.com/article/10.1186/s13561-026-00809-w |